Liberating Technologies Inc. (LTI), a Coapt research and development company, has been awarded a $2 million grant to fund the development of a prosthetic foot with modes for running and for walking. The grant is a Small Business Innovation Research (SBIR) Direct to Phase II grant from the Eunice Kennedy Shriver National Institute of Child Health and Human development at the National Institutes of Health (NIH).
The project aims to further develop and test the bimodal foot that would be reimbursable under existing L-codes, unlike other running feet.
“The lack of accessibility of higher activity prostheses is a significant barrier to physical activity for many individuals with lower-limb loss. We are extremely excited to be awarded this competitive NIH grant to further the development of our bimodal foot, which has the potential to address the access barrier and help those who want to be physically active but cannot afford a running-specific prosthesis,” said Jen Johansson, principal investigator and director of research at LTI.
LTI was also awarded a Phase I SBIR grant by NIH to explore the feasibility of a remote monitoring system for pediatric orthotic treatment.
